New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
05:16 EDTHSICHenry Schein to acquire five companies from Arseus, terms not disclosed
Henry Schein announced the signing of an agreement that will further strengthen its European dental and technology businesses. Under the agreement, the company will acquire 100% ownership of five businesses operating in three European countries from Arseus. Together, the dental practice management software company and the dental and lab distribution companies represent annual sales of approximately $97M. Henry Schein did not disclose financial terms of the transaction. Henry Schein expects the Arseus transaction to be dilutive to FY14 EPS by approximately 3c.
News For HSIC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
10:45 EDTHSICHenry Schein Medical to offer Atossa Genetics' FullCYTE Breast Aspirator
Earlier today, Atossa Genetics (ATOS) announced that Henry Schein Medical, the U.S. Medical business of Henry Schein (HSIC), will offer its customers the FullCYTE Breast Aspirator. The Atossa FullCYTE Breast Aspirator is used by OB/GYNs, primary care physicians and women's clinics to collect fluid from breasts for subsequent cytological evaluation. Dr. Steven C. Quay, Chairman, President & CEO of Atossa Genetics, commented, "Working with Henry Schein is an important step forward in making the FullCYTE Breast Aspirator available nationwide. Henry Schein is an industry leader and its multi-channel sales organization allows for expanded reach into multiple market segments within health care for our device. We are thrilled to work with a company such as Henry Schein and believe our arrangement will contribute positively to our upcoming nationwide launch." Shares of Atossa Genetics are up almost 48% in morning trading.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use